Castlight Health (CSLT) Earns Media Sentiment Rating of 0.22
News coverage about Castlight Health (NYSE:CSLT) has trended somewhat positive this week, Accern reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Castlight Health earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave media stories about the software maker an impact score of 45.5836388321456 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Several equities analysts recently issued reports on CSLT shares. William Blair started coverage on Castlight Health in a research note on Wednesday, June 20th. They set an “outperform” rating on the stock. Zacks Investment Research raised Castlight Health from a “hold” rating to a “buy” rating and set a $5.00 target price on the stock in a research note on Wednesday, July 11th. ValuEngine raised Castlight Health from a “hold” rating to a “buy” rating in a research note on Friday, July 20th. Dougherty & Co increased their target price on Castlight Health from $6.00 to $7.00 and gave the stock a “buy” rating in a research note on Monday, July 23rd. Finally, Chardan Capital lowered Castlight Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $6.00 to $4.80 in a research note on Tuesday, July 31st. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $5.56.
CSLT remained flat at $$3.05 during mid-day trading on Friday. The company had a trading volume of 533,097 shares, compared to its average volume of 468,089. Castlight Health has a 1 year low of $2.65 and a 1 year high of $5.95. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.02. The firm has a market cap of $420.16 million, a price-to-earnings ratio of -11.73 and a beta of 1.14.
In other Castlight Health news, CFO Mangini Siobhan Nolan sold 5,619 shares of the stock in a transaction dated Friday, July 20th. The stock was sold at an average price of $5.18, for a total value of $29,106.42. Following the sale, the chief financial officer now owns 141,109 shares of the company’s stock, valued at approximately $730,944.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Seth B. Cohen sold 25,000 shares of the stock in a transaction dated Monday, July 23rd. The shares were sold at an average price of $5.47, for a total value of $136,750.00. Following the completion of the sale, the director now directly owns 297,716 shares in the company, valued at approximately $1,628,506.52. The disclosure for this sale can be found here. Insiders sold a total of 74,923 shares of company stock worth $367,546 in the last ninety days. 22.58% of the stock is owned by corporate insiders.
Castlight Health Company Profile
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.
Further Reading: Risk Tolerance
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.